This update is in follow-up to the FDA Drug Safety Communication: Â Important drug interactions between Victrelis (boceprevir) and ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitor drugs on 2/4/2012. Safety Announcement [4-26-2012] The U.S. Food and Drug Administration (FDA) is notifying the public that co-administration of Victrelis (boceprevir), a hepatitis C virus (HCV) protease inhibitor, along…
Webinar: Practical Advice for Preventing Surgical Fires–Safety Strategies from the Front Lines
<!– –> <!– Page Last Updated: 04/26/2012 –> Page Last Updated: 04/26/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
In Vitro Companion Diagnostic Devices
<!– –> <!– Page Last Updated: 04/25/2012 –> Page Last Updated: 04/25/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Consumer Information on: Epic? Vascular Self-Expanding Stent System
<!– –> <!– Page Last Updated: 04/25/2012 –> Page Last Updated: 04/25/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Comunicado de la FDA sobre la seguridad de los medicamentos: Información actualizada sobre el riesgo de coágulos de sangre en las mujeres que toman pastillas anticonceptivas que contienen drospirenona
Esta actualización se hace a manera de seguimiento al Comunicado de la FDA sobre la seguridad de medicamentos del 26 de septiembre del 2011: Seguimiento al estudio de seguridad sobre el posible aumento en el riesgo de coágulos de sangre con las pastillas anticonceptivas que contienen drospirenona [PÃldoras anticonceptivas que contienen drospirenona – Actualización de…
Summary Information for: Epic? Vascular Self-Expanding Stent System
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Summary Information for: BONDTM ORACLETM Human Epidermal Growth Factor Receptor 2 (HER2 ) Immunohistochemical (IHC) System
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Consumer Information on: BOND? ORACLE? Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemical (IHC) System
<!– –> <!– Page Last Updated: 04/25/2012 –> Page Last Updated: 04/25/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
X-Rock: Recall
<!– –> <!– Page Last Updated: 04/25/2012 –> Page Last Updated: 04/25/2012 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Class I Medical Device Recall: Roche Diagnostics Operations, Inc., Elecsys Troponin I and Elecsys Troponin I STAT Immunoassays
Recall Class: Class I Date Recall Initiated: March 12, 2012 Product: Elecsys Troponin I and Elecsys Troponin I STAT Immunoassays Lot numbers: 163176, 163177 Use: Elecsys Troponin I and Elecsys Troponin I STAT Immunoassays are used to determine heart damage as an aid in the diagnosis of a heart attack. Distribution Dates: June 29, 2011…